Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients

Clinical trial NCT04844866 · RECRUITING

Trial details

NCT number: NCT04844866
Sponsor: Miltenyi Biomedicine GmbH
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-cell Lymphoma

Start date: 2021-08-18
Primary completion: 2025-01-15
Enrollment: 213

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.